Michael Armaneous

Michael Armaneous

Auto-generated profile, based on publicly available information

Michael Armaneous

David Geffen School of Medicine at UCLA—Department of Head & Neck Surgery Los Angeles California USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2023 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
LELauran Evans
Lauran Evans
SSSarah Requa Sutton
Sarah Requa Sutton
KEKristen Echanique
Kristen Echanique
MAMichael Armaneous
Michael Armaneous
VPVictoria Palacios
Victoria Palacios
MJMaie St. John
Maie St. John
Background: Cutaneous angiosarcoma is an aggressive tumor commonly found in the head and neck region. There is no consensus regarding the definitive treatment for angiosarcoma.Methods: This was a retrospective chart review that evaluated 64 patients from 1983 to 2019. Demographic and clinical variables were examined for impact on recurrence using the time to recurrence and the overall survival in Kaplan–Meier curves.Results: Average age at diagnosis was 71 (32–95) years, with a 2.8 male: female ratio. Surgery was utilized in 62% of patients, with mean defect size of 11.4 ± 8.1 cm. Recurrence was found in 70% of patients, and mean time to recurrence was 15.3 ± 12.3 months. Decreased recurrence was associated with use of intraoperative frozen section analysis (p = .036) and negative margins (p = .086). Two‐year overall survival was 80%, and recurrence free survival was 30%.Conclusions: Negative margins are associated with decreased recurrence, and intraoperative frozen section analysis may be considered to obtain preliminary surgical margins.Level of Evidence: 4.